【Abnova】March 2026 Revenue NT$34 Million (YoY -4.1%)
NQ Score
3/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Abnova's revenue for March 2026 was NT$34 million, a decrease of 4.1% year-over-year. The company is in the Biotechnology and Medical Care industry.
AI Analysis
Frequently Asked Questions
- Q: What was Abnova's revenue in March 2026?
- A: It was TWD 34.4 million, a decrease of 4.1% year-over-year.
- Q: What does Abnova sell?
- A: It sells antibodies, proteins, and reagent kits online for use by researchers at universities and pharmaceutical companies.
- Q: How should we view Abnova's performance?
- A: Since monthly sales are influenced by how its customers spend their research budgets, it needs to be viewed from a longer-term perspective (quarterly or full-year).